Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs

Guangzhong Xu(Capital Medical University), Qing Fan(Beijing Shijitan Hospital)
Oncology Letters
January 25, 2018
Cited by 2


Related Papers